AID is manufacturer of the first multi-colour FLUOROSPOT Reader System and has also developed the world's most used ELISPOT Reader Systems. Beside other imaging devices, AID offers assay kits for the routine detection of various infection diseases and gen
Die AID GmbH mit Firmensitz in Südwestdeutschland auf der Schwäbischen Alb, produziert und vermarktet seit 1989 weltweit diagnostische Produkte, Geräte und dazu gehörende Computerprogramme im Bereich Immunologie und Infektionskrankheiten.
AID is manufacturer of the first multi-colour FLUOROSPOT Reader System and has also developed the world's most used ELISPOT Reader Systems. Beside other imaging devices, AID offers assay kits for the routine detection of various infection diseases and gen
AID is manufacturer of the first multi-colour FLUOROSPOT Reader System and has also developed the world's most used ELISPOT Reader Systems. Beside other imaging devices, AID offers assay kits for the routine detection of various infection diseases and gen
AID is manufacturer of the first multi-colour FLUOROSPOT Reader System and has also developed the world's most used ELISPOT Reader Systems. Beside other imaging devices, AID offers assay kits for the routine detection of various infection diseases an
Bei Biogen entdecken, entwickeln, produzieren und vertreiben wir innovative Medikamente für Menschen mit schweren neurologischen, hämatologischen und Autoimmun-Erkrankungen
Dr. Christina Ednalino is a board certified rheumatologist in in Brooklyn, NY, and in Queens, Long Island, and specializes in Rheumatology, Arthritis , Gout, Lupus, SLE. Joints, Rheumatoid arthritis, Osteoarthritis, Systemic Lupus Erythematosus,
Autoimmun
resolvingIMAGES is the exclusive Australian and New Zealand agent for all of the Autoimmun Diagnostika (AID), Mabtech and Avans products. These ongoing partnerships will provide equipment, diagnostic kits and support for the clients in this region.
Bei Biogen entdecken, entwickeln, produzieren und vertreiben wir innovative Medikamente für Menschen mit schweren neurologischen, hämatologischen und Autoimmun-Erkrankungen
Bei Biogen entdecken, entwickeln, produzieren und vertreiben wir innovative Medikamente für Menschen mit schweren neurologischen, hämatologischen und Autoimmun-Erkrankungen